Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851.
Ginsberg SJ, Anderson JR, Gottlieb AJ, Bloomfield CD, Norton L, Barcos M, Holland JF. Ginsberg SJ, et al. Among authors: holland jf. NCI Monogr. 1987;(5):77-80. NCI Monogr. 1987. PMID: 2448657 Clinical Trial.
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
Gottlieb AJ, Anderson JR, Ginsberg SJ, Bloomfield CD, Norton L, Barcos M, Peterson BA, Nissen N, Henderson ES, Holland JF. Gottlieb AJ, et al. Among authors: holland jf. Cancer. 1990 Nov 1;66(9):1888-96. doi: 10.1002/1097-0142(19901101)66:9<1888::aid-cncr2820660906>3.0.co;2-k. Cancer. 1990. PMID: 1699653 Clinical Trial.
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
Vinciguerra V, Propert KJ, Coleman M, Anderson JR, Stutzman L, Pajak TF, Nissen NI, Frizzera G, Gottlieb A, Holland JF. Vinciguerra V, et al. Among authors: holland jf. J Clin Oncol. 1986 Jun;4(6):838-46. doi: 10.1200/JCO.1986.4.6.838. J Clin Oncol. 1986. PMID: 2423652 Clinical Trial.
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
Coleman M, Rafla S, Propert KJ, Glicksman A, Peterson B, Nissen N, Brunner K, Holland JF, Anderson JR, Gottlieb A, Kaufman T. Coleman M, et al. Among authors: holland jf. Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):639-45. doi: 10.1016/s0360-3016(98)00071-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9635714 Clinical Trial.
619 results